Equities

Immunovia AB (publ)

Immunovia AB (publ)

Actions
  • Price (SEK)0.695
  • Today's Change0.695 / --
  • Shares traded37.07k
  • 1 Year change-46.19%
  • Beta--
Data delayed at least 20 minutes, as of Oct 09 2024 10:24 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of SEK
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments77106287
Total Receivables, Net0.943.654.48
Total Inventory02.022.15
Prepaid expenses2.783.913.06
Other current assets, total------
Total current assets81116297
Property, plant & equipment, net154847
Goodwill, net------
Intangibles, net2.55134147
Long term investments0.513.503.03
Note receivable - long term------
Other long term assets------
Total assets99301494
LIABILITIES
Accounts payable8.481.583.07
Accrued expenses151520
Notes payable/short-term debt000
Current portion long-term debt/capital leases2.504.876.11
Other current liabilities, total3.922.463.37
Total current liabilities302433
Total long term debt1.793327
Total debt4.293833
Deferred income tax------
Minority interest------
Other liabilities, total------
Total liabilities325760
SHAREHOLDERS EQUITY
Common stock2.261.131.13
Additional paid-in capital1,1361,0161,016
Retained earnings (accumulated deficit)(1072)(774)(583)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total----0.00
Total equity67244434
Total liabilities & shareholders' equity99301494
Total common shares outstanding914949
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.